# cAMP and Protein Kinase A

> cAMP levels reflect the balance of synthesis and breakdown; PKA responses depend on which targets are nearby. Follow cyclic AMP from the broken-cell experiment that revealed an intracellular messenger, through the enzymes that make and destroy it, to protein kinase A, the enzyme it switches on. Then use target proteins, anchoring and local cAMP dynamics to explain how the same messenger produces different responses across cells and within one cell.

Course: Cell Signaling (G-protein-coupled receptors and second messengers). Level: advanced university and graduate. About 14 minutes.
Lesson page (link this one when citing): https://stemhop.com/lessons/camp-and-pka/

Builds on: GPCRs and Trimeric G Proteins · Phosphorylation: Kinases and Phosphatases · Adaptors, Docking Proteins and Scaffolds

## What you'll learn

- State what makes a molecule a second messenger, using cAMP, and describe the broken-cell experiment that found it.
- Describe how adenylyl cyclase makes cAMP and phosphodiesterase destroys it, and how Gs and Gi set the rate of the cyclase.
- Explain how cAMP switches on protein kinase A by relieving the hold of two regulatory subunits on two catalytic subunits.
- Explain how one messenger and one kinase give different answers in different cells and in different parts of one cell.

**Adrenaline binds outside a liver cell, yet enzymes in the cytosol change their activity.** The first film showed the relay through cyclic AMP (cAMP); here is the experiment that proved it, then its main reader, protein kinase A (PKA).

## Finding the messenger in broken cells

Earl Sutherland later recalled “a widespread feeling among biologists that hormone action could not be studied meaningfully in the absence of organized cell structure.” His laboratory tested it on liver, where adrenaline switches on phosphorylase to start glycogen breakdown.

The researchers homogenized liver and centrifuged it. A pellet held particles later traced to membrane fragments; the clear **supernatant** held phosphorylase. Every tube also held ATP and magnesium, which both steps needed.

**Predict.** Hormone added to the supernatant alone left phosphorylase off. Which of these should switch it on: hormone with supernatant plus a little pellet mixed back in, or liquid from a tube of hormone and pellet, added to supernatant?

> **Check your prediction.** Both did. So the hormone acts on the pellet, which hands something to the soluble fraction, where the phosphorylase is. That liquid still worked after boiling and passed through a dialysis membrane, so the transferred factor was small and not an enzyme. Nothing in the tubes was alive: the relay was chemistry.

The paper, by Theodore Rall, Sutherland and Jacques Berthet, came out in 1957. The factor was an adenine nucleotide with one phosphate bonded to the ribose at both the 3′ and 5′ carbons, closing a ring: adenosine 3′,5′-monophosphate, or **cyclic AMP**. David Lipkin’s chemistry group had isolated the same compound from ATP treated with barium hydroxide, without hormone, and later established its structure.

Sutherland called the hormone the **first messenger** and cAMP the **second messenger**. Here, a second messenger is a small intracellular molecule or ion whose level changes after an extracellular first messenger binds, and that carries the signal to intracellular effectors. cAMP is made for the purpose; calcium, another second messenger, is instead released from internal stores.

**The one idea.**

cAMP levels reflect the balance of synthesis and breakdown; PKA responses depend on which targets are nearby.

**Scope:**

This rule covers the classical cAMP–PKA pathway. The balance equation below assumes first-order, unsaturated breakdown; other proteins also read cAMP.

## How much cAMP accumulates?

The first film showed a source filling the pool and a sink draining it; here are the reaction details and the arithmetic behind that picture.

The source is **adenylyl cyclase**. Its hormone-sensitive forms, in the plasma membrane, convert ATP to cAMP and release pyrophosphate. Whether Gi lowers its activity depends on which cyclase form the cell makes. The prerequisite lesson on GTPase switches develops the G-protein cycle.

The sink is **phosphodiesterase**, which hydrolyses the ring’s 3′ bond to leave 5′-AMP.

*Figure (AI-generated illustration).* The cAMP level settles where synthesis matches breakdown: Gs raises synthesis, Gi lowers it for some cyclase forms, and phosphodiesterase removes cAMP. Image: a cell membrane with the enzyme adenylyl cyclase in it. Gs pushes it up and Gi pushes it down; Gi inhibits only some forms of the cyclase. The cyclase makes a pool of cAMP in the cytosol, and a second enzyme, phosphodiesterase, removes cAMP and leaves 5′-AMP.

The film’s curve assumed first-order removal, proportional to cAMP concentration (the box above gives its scope). At steady state:

> **steady-state [cAMP] = synthesis rate ÷ breakdown rate constant**

For example, 2 micromolar per second ÷ 4 per second = 0.5 micromolar.

**Predict.** If both the synthesis rate and the first-order breakdown constant double, what happens to the steady cAMP level?

> **Check your prediction.** Unchanged: the same factor appears above and below the division. Turnover is faster, so the level responds more quickly when either rate changes.

**Predict.** If cAMP rises high enough to saturate phosphodiesterase, can you still use the simple division rule unchanged?

> **Check your prediction.** No. A saturated phosphodiesterase removes cAMP at a rate no longer proportional to its concentration, so no single breakdown constant describes it.

Raising synthesis and lowering breakdown multiply their effects; the lesson on turning signals off takes up signal duration. Theophylline inhibits phosphodiesterase and strengthens cAMP-linked hormone responses, one of Sutherland’s tests for a cAMP messenger. Caffeine, a close relative, inhibits phosphodiesterase in vitro, although at concentrations reached by drinking coffee it is thought to act mainly at adenosine receptors.

The cAMP level is only half the explanation; the next question is what its kinase can reach.

**Film transcript: PKA: The Target Sets the Response**

### Film transcript: PKA: The Target Sets the Response

Synthesis and breakdown set the cAMP level. Once that messenger activates PKA, why do heart and fat cells respond differently? The messenger is common, but the reachable machinery need not be. That is the puzzle. At low cAMP, PKA rests as paired regulatory and catalytic subunits. Each catalytic subunit is a complete kinase. Each regulatory partner keeps one catalytic site inactive. The regulatory pair acts as an off switch until messenger arrives. A kinase modifies a target protein by transferring phosphate from ATP. The target must enter a groove. A regulatory segment mimics a target and occupies that groove first. Blocking the groove prevents genuine targets from receiving phosphate.

cAMP binds the regulatory subunits and changes their shape. Their blocking segments release the grooves. In the classical model, catalytic subunits come away free. Evidence suggests anchored complexes can act nearby without fully coming apart. Either picture exposes catalytic activity to targets within reach.

Now place the same active PKA across both cells. Both cells receive the same messenger level and display the same kinase. One cell offers green target strips, while the other offers different strips. Must their responses match?

No. An active PKA can modify only compatible targets it reaches. Different cells make different target proteins, so identical messenger and kinase activity can produce different cellular actions. The response follows the proteins present, not a special kind of cAMP. In fat, reachable targets include hormone-sensitive lipase and perilipin, supporting fat breakdown. In heart, other targets alter calcium entry, cycling, contraction, and relaxation. Liver offers another set, including enzymes that control glycogen. The relay is shared; the target set differs. Reach also matters within one cell. An anchoring protein can hold PKA beside a selected substrate.

The address narrows which target can meet the active kinase. Nearby cyclase supplies cAMP, while nearby phosphodiesterase removes it. Experiments reveal local cAMP regions and receptor-specific PKA activity. Local production, local removal, binding, and restricted movement may all contribute. Their importance varies and remains debated. The local patterns are observed; the mechanism is not fully settled. Activation therefore opens the catalytic groove, but access gives the signal meaning. The text now tests that groove with competition and examines the evidence for local signalling. Those experiments separate what is established from what is proposed.

From the film

- PKA responses depend on which targets are nearby.
- Regulatory subunits block PKA catalytic sites until cAMP relieves the inhibition.
- Different cells offer PKA different target proteins, so the same pathway can produce different responses.
- Within one cell, anchoring and local cAMP dynamics help direct PKA toward selected targets.

## How cAMP relieves PKA inhibition

The second film showed each of PKA’s two **regulatory** subunits blocking the groove of one of its two **catalytic** subunits (each a complete kinase) with a target-mimicking segment. Here is why that segment fits, at the level of sequence.

Many preferred protein kinase A (PKA) targets place a serine or threonine just after basic residues, often a pair of arginines (Arg-Arg-X-Ser/Thr). The regulatory subunit’s blocking stretch copies that pattern. In type I regulatory subunits the phosphate-receiving position holds a residue that cannot accept one: a **pseudosubstrate**, which fits but cannot be phosphorylated.

**Predict.** A free target-like peptide, with alanine in place of the serine, is added to purified catalytic subunit. If the experiment supplies far more real substrate, should inhibition become easier or harder to detect?

> **Check your prediction.** Harder. Real substrate competes for the same groove, so enough substrate can displace a free pseudosubstrate peptide. In the whole complex the regulatory subunit grips the catalytic subunit over a much larger surface, so extra substrate does not release it; cAMP does.

Four cAMP, two on each regulatory subunit, relieve the hold. In the classical model, the catalytic subunits come away free. There is evidence that anchored PKA can act on nearby targets without fully coming apart, so take release as the textbook picture, which may not hold everywhere.

## Different cells offer different targets

Here is what the film’s targets do:

- **Liver:** Protein kinase A (PKA) phosphorylates phosphorylase kinase, which activates glycogen phosphorylase (the overview lesson on signal transduction walks through that cascade), and phosphorylates glycogen synthase, inhibiting glycogen synthesis.
- **Heart:** PKA phosphorylates phospholamban, releasing a brake on the pump that returns calcium to its internal store, and troponin I on contractile filaments. PKA activity also increases calcium entry through L-type calcium channels, producing a stronger beat and faster relaxation.
- **Fat:** perilipin, the film’s second fat target, is the protein coating the fat droplet.

Catalytic subunits reaching the nucleus can phosphorylate cAMP response element-binding protein (CREB) and change gene expression over a longer time.

*Figure (AI-generated illustration).* The same cAMP–PKA relay produces different responses because liver, heart and fat cells place different targets within the kinase's reach. Image: three side-by-side schematic cells labelled liver, heart and fat. Each has the same gold chain of cAMP and protein kinase A under the membrane, with an arrow to different target proteins: phosphorylase kinase and glycogen synthase in liver, phospholamban and troponin I in heart, hormone-sensitive lipase and perilipin in fat.

## Different addresses within one cell

In heart muscle, Hayes, Brunton and colleagues reported that isoproterenol acting at β-adrenergic receptors and prostaglandin E1 both raised cAMP, yet only isoproterenol activated the particulate pool of protein kinase A (PKA) that pellets with cell structures. In 1983 Buxton and Brunton named the result: compartments of cAMP and protein kinase. About twenty years later, Zaccolo and Pozzan imaged local regions of high cAMP in stimulated heart cells from newborn rats.

**Predict.** If a phosphodiesterase helps confine one local cAMP signal, what should happen when that enzyme is inhibited?

> **Check your prediction.** The signal should spread farther or last longer, so separate responses may begin to mix. That would support a role for local breakdown without proving it is the only barrier.

The film’s local clouds show **cAMP compartmentation**: cAMP concentrations and effects are not uniform across a cell. Its anchoring proteins are **A-kinase anchoring proteins (AKAPs)**, from the lesson on adaptors and scaffolds; they often hold a phosphodiesterase beside PKA too.

Which candidate contributes most may depend on the preparation. Agarwal, Clancy and Harvey found support for buffering by PKA. Richards and colleagues found similarly slow movement in adult ventricular myocytes but attributed it to tortuosity, the winding paths around cellular obstacles, because saturating binding sites did not speed cAMP. Other studies argue against phosphodiesterase alone explaining gradients. The compartments are observed; their mechanism is not settled.

### Design problem

A heart cell and a liver cell both raise cAMP when adrenaline arrives. In liver, glucagon is the main hormone using this route, and adrenaline also acts through calcium. Design how heart contracts harder while liver releases glucose, then explain how one cell could keep two cAMP signals apart.

> **One way to do it.** Keep receptor, Gs, adenylyl cyclase, cAMP and PKA as the shared relay. In heart, place phospholamban, troponin I and L-type calcium channels with their brake protein Rad within PKA’s reach; PKA phosphorylation of Rad lets more calcium enter. In liver, supply phosphorylase kinase and glycogen phosphorylase, plus glucose 6-phosphatase so glucose can leave.
>
> Within one cell, put each receptor and cyclase near an AKAP carrying PKA, its substrate and a phosphodiesterase, with cAMP-binding proteins or obstacles slowing spread; several mechanisms may contribute.

## Going deeper

### How the kinase structure established the blocked groove

Walsh, Perkins and Krebs described cAMP-dependent protein kinase in 1968. In 1991 Susan Taylor’s laboratory and Janusz Sowadski’s [crystallography](https://stemhop.com/methods/x-ray-crystallography/) group produced the first three-dimensional structure of a protein kinase, PKA’s catalytic subunit. It has two lobes: ATP lies under the small lobe, substrate follows the large lobe, and phosphate transfer occurs in the cleft. Their crystal held a 20-residue pseudosubstrate from a separate inhibitor protein; later structures placed a regulatory subunit’s inhibitor sequence in the same groove. The human genome encodes about 500 protein kinases whose catalytic cores vary around this fold.

### Other cAMP readers

Protein kinase A (PKA) is not the only direct reader. Epac is a cAMP-activated exchange factor for the small GTPase Rap. Cyclic-nucleotide-gated channels, including those in olfactory neurons, open when cAMP binds. These effectors sit outside the guiding rule’s PKA-response clause.

---

From STEMhop (https://stemhop.com), free lessons by Christopher Deppmann. Lesson text © the authors. Practice questions: https://stemhop.com/lessons/camp-and-pka/
